A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

NCT00800917 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Temsirolimus
DRUG: Bevacizumab

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]
[object Object]
[object Object]